Evaxion A/S (EVAX) stock
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.78+0.01 (+0.36%)
Close on Nov 17, 2026Market cap $23.19MP/E –Yield –
Evaxion A/S price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Evaxion A/S's price to sales ratio was 2.5× on Nov 11, 2026, against 1.9× a year earlier. Over the last 3 years it ranged from 0.5× to 156.2×, with a median of 3.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.5× | +0.9 |
| 2025 | Dec 31, 2025 | 1.5× | −30.1 |
| 2024 | Dec 31, 2024 | 31.7× | – |
See a number that looks wrong?